RAPT Therapeutics Inc. (RAPT) - Uzoq muddatli qarzning kapitalga koeffitsiyenti

rapt.com - RAPT emitenti grafik logotipi

RAPT Therapeutics, Inc. (RAPT) umumiy immunitetni zaiflashtirmagan holda, allergik yallig'lanishning maqsadli davolash uchun selektiv molekulalarni ishlab chiqadi. Narx xarakteristikasi (separate_debt_long_eq) 0.00 miqdorida qayd etilgan, bioteknologiya kompaniyasining muvaffaqiyati esa uning nomzodlarining xavfsizligi va patent tozaligiga bog'liq. Kompaniyaga tegishli istiqbollar tijoratlashtirilgan mahsulotlarning yo'qligi va laboratoriyalardagi klinik sinovlarning qat'iy tartibga soluvchi nazorati bilan cheklangan.

rapt.com (RAPT): Uzoq muddatli qarzning o'z kapitaliga nisbati 04.07.2022dan 14.03.2026gacha

RAPT Therapeutics (RAPT) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya narxi va konsensus maqsadli narx:
Kotirovkalar grafigi rapt.com|RAPT - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati RAPT Therapeutics, Inc.|RAPT - Korxona qiymati
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati RAPT Therapeutics|RAPT - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati rapt.com|RAPT - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati RAPT Therapeutics, Inc.|RAPT - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati RAPT Therapeutics Inc.|RAPT - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati RAPT Therapeutics, Inc.|RAPT - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi RAPT Therapeutics|Tezkor likvidlik ko‘rsatkichi rapt.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
RAPT - Kompaniyaning sof foydasi
Kompaniyaning umumiy tahlili:rapt.com - RAPT
RAPT Therapeutics brend mahsuloti

Investorlar moliyaviy barqarorlikni va kompaniyaning uzoq muddatli istiqbolda tashqi qarzlarga qanchalik bog'liqligini baholash uchun ushbu ko'rsatkichdan foydalanadilar. Ushbu uzoq muddatli qarz yuklamasi grafigidagi uzoq muddatli qarzning kapitalga nisbati RAPT Therapeutics, Inc. (RAPT) kompaniyasining yetarli mablag'ga ega bo'lmaslik xavfini ko'rsatadi, uning faoliyati klinik sinovlar bosqichi bilan cheklangan va tartibga soluvchi qarorlarga kritik darajada bog'liqdir.

Muhim raqobatchilar

argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati DNTH (Dianthus Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Pharvaris Pharma (PHVS)|ABCL - Uzoq muddatli qarzning o'z kapitaliga nisbati|tourmalinebio.com (TRML) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Precigen (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pharming Group NV|Uzoq muddatli qarzning o'z kapitaliga nisbati NKTR|Uzoq muddatli qarzning kapitalga nisbati Upstream Pharma|Uzoq muddatli qarzning o'z kapitaliga nisbati Zenas Biopharma Inc (ZBIO)|immunome.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Uzoq muddatli majburiyatlarning kapitalga nisbati|SEPN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti PVLA (Pieris Corp)|SVRA: Uzoq muddatli qarzning kapitalga nisbati|rigel.com (RIGL) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati AnaptysBio|Astria Therapeutics Inc - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati ENGN (enGene Bio)|Uzoq muddatli kreditlarning kapitalga nisbati JBIO|Aclaris Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KYTX|TLSA: Uzoq muddatli qarzning o'z kapitaliga nisbati|Cabaletta Bio Inc. - Uzoq muddatli kreditlarning kapitalga nisbati|VTYX: Uzoq muddatli qarzning kapitalga nisbati|Theratechnologies, Inc - Uzoq muddatli qarzning kapitalga koeffitsiyenti|AVTX (Avalo Therapeutics, Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati eledon.com ELDN|Uzoq muddatli qarzning o'z kapitaliga nisbati Agenus Inc. (AGEN)|CLYM (Climb Bio Inc.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ZURA (Zura Bio Limited)|Uzoq muddatli qarzning kapitalga nisbati aTyr Pharmaceuticals ATYR|ADAG - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati IMA|STTK: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Equillium (EQ)|Uzoq muddatli qarzning o'z kapitaliga nisbati CNTB|Uzoq muddatli qarzning kapitalga nisbati Immunic Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati ATRA (Atara Biotherapeutics)|Uzoq muddatli kreditlarning kapitalga nisbati IFRX|Uzoq muddatli qarzning kapitalga nisbati XFOR (X4 Pharmaceuticals, Inc.)|Uzoq muddatli qarzdorlikning kapitalga nisbati Adicet Bio Inc. (ACET)|Celularity Corp - Uzoq muddatli qarzning kapitalga nisbati|INmune Bio Corporation (INMB) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Barinthus Biotherapeutics (BRNS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|KZR - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati SABS|AKTX: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ENLV|Uzoq muddatli qarzdorlikning kapitalga nisbati q32bio.com|Uzoq muddatli qarzning o'z kapitaliga nisbati GeoVax Labs, Inc. GOVX|EDSA: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|iBio - Uzoq muddatli qarzning kapitalga nisbati|Carisma Therapeutics (CARM) - Uzoq muddatli qarzning o'z kapitaliga nisbati|XTLB (XTL Biopharmaceuticals, Ltd.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|BOLT - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati HCW Biologics, Inc.|APVO: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati AIM|Uzoq muddatli qarzning kapitalga nisbati aditxt.com (ADTX)|Uzoq muddatli qarzning o'z kapitaliga nisbati GRI Bio Corp GRI|XRTX (XORTX Corp) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|HIND: Uzoq muddatli qarzning o'z kapitaliga nisbati|revbiosciences.com - Uzoq muddatli kreditlarning kapitalga nisbati|Indaptus Therapeutics, Inc. (INDP) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati SCNI (Scinai Immunotherapeutics Ltd)|CALI (CalciMedica Inc) - Uzoq muddatli qarzning kapitalga nisbati|AFMD: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ALLK|Uzoq muddatli qarzning kapitalga nisbati hookipapharma.com (HOOK)|Uzoq muddatli qarzning o'z kapitaliga nisbati IGM Biosciences IGMS|Uzoq muddatli qarzning kapitalga koeffitsiyenti ITOS|OCEA - Uzoq muddatli qarzning o'z kapitaliga nisbati|TC BioPharm Ltd (TCBP) - Uzoq muddatli qarzning o'z kapitaliga nisbati|THRD: Uzoq muddatli qarzning kapitalga nisbati